Somatostatin receptor profile in pituitary thyrotroph adenomas

E Thodou, G Kontogeorgos - Clinical Neurology and Neurosurgery, 2020 - Elsevier
Objectives Thyrotroph adenomas are the most infrequent adenohypophysial tumors.
Somatostatin (SST) inhibits hormone secretion and suppresses cell proliferation. SST …
被引用次数：11 相关文章

Somatostatin receptor profile in pituitary thyrotroph adenomas.

E Thodou, G Kontogeorgos - Clinical Neurology and Neurosurgery, 2020 - europepmc.org
Objectives Thyrotroph adenomas are the most infrequent adenohypophysial tumors.
Somatostatin (SST) inhibits hormone secretion and suppresses cell proliferation. SST …

[引用][C] Somatostatin receptor profile in pituitary thyrotroph adenomas

E Thodou, G Kontogeorgos - Clinical Neurology and Neurosurgery, 2020 - cir.nii.ac.jp
Somatostatin receptor profile in pituitary thyrotroph adenomas | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

Somatostatin receptor profile in pituitary thyrotroph adenomas

E Thodou, G Kontogeorgos - Clinical neurology and …, 2020 - pubmed.ncbi.nlm.nih.gov
Objectives Thyrotroph adenomas are the most infrequent adenohypophysial tumors.
Somatostatin (SST) inhibits hormone secretion and suppresses cell proliferation. SST …

Somatostatin receptor profile in pituitary thyrotroph adenomas

KG Thodou E - 2020 - ir.lib.uth.gr
Objectives: Thyrotroph adenomas are the most infrequent adenohypophysial tumors.
Somatostatin (SST) inhibits hormone secretion and suppresses cell proliferation. SST …